AzTrials
AzTrials

Neck PainNCT00134225

Study to Demonstrate That Muscle Pattern Recognition (MPR) is an Effective Evaluation Tool for Musculoskeletal Neck or Back Pain

A study testing Muscle Pattern Recognition (MPR) in people with Neck Pain and Low Back Pain, run by iTech Medical, Inc. at 4 sites in 2 countries.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The investigators hypothesize that non able-bodied participants with reported acute, sub-acute, or chronic symptoms of neck or back pain of a musculoskeletal origin will have magnetic resonance imaging (MRI), X-ray and blood parameters that do not demonstrate a statistical difference between "normal" (able-bodied)… Read more about this study

Who is it for?
Ages 18 to 62 yearsHealthy volunteers can take part
Conditions the study is for
Neck Pain, Low Back Pain
What is being tested?
Muscle Pattern Recognition (MPR)
Type of treatment
Medical device
How many people
480 participants
Where
4 sitesin 2 countries
Study dates
Apr 2005to Dec 2006
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 62 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Individuals may participate in this study if they meet the following criteria:
  • 18-62 years of age; male or female.
  • 4 foot 10 inches to 6 foot 5 inches in height
  • No prior back or neck surgery, or structural deformity of the spine
  • No orthopedic injury/illness/surgery limiting range of motion of the shoulders
  • No ongoing treatments for back or neck pain/injury from a health professional in the last two years.
Show all 10Show fewer
  • No prior loss of work time due to a neck or back injury/illness
  • Laboratory studies: complete blood count (CBC); sedimentation rate; creatinine phosphokinase (CPK); calcium; phosphorus; pregnancy test if female; and drug screen. Laboratory studies will be examined by a physician investigator to determine if the findings will exclude the participant from participating successfully in study activities. A positive pregnancy test or drug screen will automatically exclude the participant from the study.
  • Clinical examination of the neck and back by two physicians in agreement that the participant may participate in the study.
  • Absence of congenital or acquired neuromuscular disease or dysfunction

Who cannot join

  • Individuals may not participate in this study if they meet the following criteria:
  • Claustrophobia or anxiety associated with being enclosed in narrow spaces
  • Muscle weakness or sensory feedback abnormalities that affect(s) gait
  • Pregnancy
  • Concurrent serious medical illness such as cancer; recent heart attack or stroke; heart rhythm disturbance requiring a pacemaker; diabetes that causes pain; numbness; or decreased circulation in the legs.
  • Alcohol or illicit drug abuse.
Show all 10Show fewer
  • History of (or concurrent) psychiatric illness necessitating ongoing "talk" therapy and/or psychotropic medications
  • History of back or neck pain lasting more than 3 days or requiring time off of work AND healthcare provider treatments within the last 2 years
  • Involved in a lawsuit or receiving worker's compensation or disability payments
  • Individuals with pacemakers or pacemaker wires; aneurysm clips; or metallic foreign bodies or metal shavings in the body.

Trial locations and contacts

4 sites in 2 countries.

Suzan D Olson, PhD, MHS, RN contact

269.329.3517

solson@midwestcct.com

4 sites in 2 countries

United States3 sites, 3 recruiting
  • Department of Neurology - UC Irvine

    Irvine, California, 92697-4275

    Neal Hermanowicz, MD

    Shari Niswonger, 949-824-8116

    Not yet recruiting
  • Midwest Consultants for Clinical Trials LLC

    Portage, Michigan, 49002

    Suzan Olson, PhD, 269-329-3517, solson@midwestcct.com

    Gail Massey, RN, 269-329-3517 ext. 522, gmassey@midwestcct.com

    Recruiting
  • Advance Clinical Research

    Salt Lake City, Utah, 84102

    Mark Passey, MD, 801-355-4126

    Kristi Newingham, 801-355-4126 ext. 110, knewingham@acr-research.com

    Not yet recruiting

Other trials in United States

Canada1 site, 1 recruiting
  • Institute de Rescherche in Physiatrie du Quebec

    Montreal, Quebec, H2K 1C1

    Genevieve Bujold, 514-527-4155, rabyr@videotron.ca

    Luc Fortran, MD

    Not yet recruiting

Other trials in Canada

About this study

Official title: Multi-Center, Multi-National Study to Demonstrate That Muscle Pattern Recognition is a Reliable and Valid Evaluation Tool for Patients Who Present With Acute, Sub-Acute, or Chronic Symptoms of Neck or Back Pain of a Musculoskeletal Origin

The investigators hypothesize that non able-bodied participants with reported acute, sub-acute, or chronic symptoms of neck or back pain of a musculoskeletal origin will have magnetic resonance imaging (MRI), X-ray and blood parameters that do not demonstrate a statistical difference between "normal" (able-bodied) volunteers.

Muscle pattern recognition (MPR) testing will show statistically different results between these groups. This statistically significant finding in MPR results will enhance a clinician's determination of clinical normality or abnormality.

If this hypothesis is demonstrated, the MPR modality will be the first quantitative tool developed for assisting in the diagnosis of the presence or absence of a musculoskeletal dysfunction in a patient population. The availability of such an evaluation tool to a healthcare provider for patients with soft tissue, non-surgical neck or back complaints will substantially improve the accuracy of diagnosis and case management decisions.

Read the detailed description

Investigators aim to use data from both the able-bodied and non able-bodied samples to create a normative database for this technology. The primary objective of populating a normative database will be to construct a reliable and valid normative database representative of the North American population for use with a discriminative analysis tool which will differentiate abnormal musculoskeletal function from normal musculoskeletal function.

Study Population: The study population will be composed of 480 asymptomatic participants (able-bodied individuals) and symptomatic (non able-bodied individuals: individuals with musculoskeletal, non-surgical injuries of the neck and back) selected first on the basis of a screening questionnaire.

Upon signing an informed consent to participate in the study, participants will complete screening questionnaires. They will be independently evaluated by two clinicians, well experienced in the field of musculoskeletal medicine, who obtain a detailed medical history with particular attention to the strict inclusion/exclusion criteria and perform a standardized physical examination. This standardized clinical examination consists of the most current "Gold Standard".

Most patients presenting with musculoskeletal complaints of the back or neck and are frequently given this diagnosis solely on the basis of the "first line" healthcare providers' history and physical examinations.

To ensure the statistical strength of the history and physical selection process for further inclusion into the study, participants will undergo two separate clinical examinations. Each will be performed independently by physicians who are specialists in two different fields of practice that commonly see neck and back pain patients and who must agree if a subject is clinically normal or not.

If selected for continued participation, each participant will undergo Magnetic Resonance Imaging (MRI) of the spine (sagittal views of the entire spine), plain X-rays of the entire spine (A/P and Lateral views), blood studies (CBC, Sedimentation Rate, CPK, Calcium, Phosphorous, Pregnancy test, drug screen) and MPR testing.

A total of 480 clinically and lab normal able-bodied/not-able bodied individuals will be selected and examined over a period of twelve months at 4 different centers.

Able-Bodied Participants:

A total of approximately 240 able-bodied participants will be divided by gender (male, female) and by age classes: specifically [18-30 years], [31-45 years], and [46-62 years]. This sample size was selected, in part, because Edgerton et al. reported that recruitment patterns of the neck or back differ dependent upon gender and our goal is to have a population of approximately 120 males and 120 females.

At the close of the study, investigators will segment the population into the three age groups mentioned, the proposed sample sizes are thought to be appropriate for statistical analysis while still capturing a variety of subject types. The overall age range was chosen to represent the main working population in North America, but to not exceed an upper age range where muscle recruitment patterns may vary on a natural evolutionary basis.

The total number of normal/able-bodied participants will be collected from 4 independent research centers in the U.S. and Canada with an expected maximum of approximately 60 individuals per center. A sub-group of 32 randomly assigned able-bodied volunteers will be scheduled for a second MPR test approximately 7 days after their initial testing to examine the reliability of the MPR evaluation tool. In the selection process, every effort will be made to avoid bias toward a non-working population (i.e. testing only in the morning or afternoon) and to obtain representative proportions of the age and race classes existing in North America.

Not Able-Bodied Participants:

Investigators aim to construct a valid and reliable profile of clinically not normal individuals diagnosed as suffering from musculoskeletal neck or back pain that will be used to confirm our hypothesis and the ability of the MPR evaluation to provide valid, reliable, and objective information for the clinician.

These 240 not able-bodied volunteers will be selected using the same inclusion/exclusion criteria and standardized medical histories and physical examinations as above. One exception to the exclusion criteria is that if a not-normal participant uses ongoing medications for control of discomfort, it will be left to the discretion of each investigator as to how that individual's medication profile may affect their pain reporting, physical performance, or compliance with the protocol steps. A 3-day medication "wash-out" will be allowed (and encouraged) if there is any concern about a participant's performance.

In order to conduct an appropriate discriminate analysis, half of the recruited participants will be an able-bodied sample of participants. Half of the participants will fall into the not able-bodied participant sample. Every effort will be made in the selection process to avoid bias toward a non-working population (i.e. testing only in the morning or afternoon) and obtain representative proportions of the age and race classes existing in North America.

During the data collection process, other clinical categories could be defined for additional statistical analysis such as the loci of symptoms (i.e. lumbar, thoracic, cervical), the level of symptoms (lower, mid, or upper back) and the laterality of symptoms (left or right). Upon analysis of the laboratory and image findings (MRI, X-ray, blood tests) other anatomic findings or variations such as degenerative disc disease, size of possible disc protrusions, Sedimentation Rate or CPK values, Schmorld's nodes, etc. may also be discussed.

Not able-bodied volunteers may have long standing back or neck pain or pain symptoms as recently as several days after a date of injury. This more immediate window of pain will be allowed to include acute events but not until or unless the individual is able to perform the nine movements necessary for the MPR testing procedure. The outer time duration of pain was chosen to include individuals with more chronic complaints, but not if other compensatory or secondary gain issues appear present such as may occur with Worker's Compensation claims, disability claims, or litigation. It is the desire of investigators to include appropriate acute, sub-acute, and chronic neck or back pain sufferers.

We believe that the design of this study will prove that the evaluation provided by the MPR testing modality should be the tool of choice for the objective evaluation and case management of patients presenting with musculoskeletal, non-surgical neck and back pain as it will differentiate "normal" (asymptomatic, able-bodied) individuals from those individuals ("not normal") with underlying biomechanical dysfunctions.

Being tested
Muscle Pattern Recognition (MPR)
Keywords
Musculoskeletal abnormality, Musculoskeletal physiology, Musculoskeletal disease, Musculoskeletal dysfunction
Medical subject headings
Neck Pain, Low Back Pain, Musculoskeletal Abnormalities, Musculoskeletal Diseases

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Muscle Pattern Recognition (MPR)Device

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. This study will demonstrate differences in muscle recruitment patterns between individuals who are "normal" (asymptomatic, able-bodied) from those individuals ("not normal") with underlying biomechanical dysfunction of the neck and back

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted24 Aug 2005 (estimated)
  2. Study startApr 2005
  3. Study completionDec 2006

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Diagnosis
Allocation
Non-randomised
Intervention model
Single group
Masking
Single blind
Enrolment
480 participants
IDs, dates and publications
ClinicalTrials.gov ID
NCT00134225
Sponsor's protocol ID
IMS MPR 480
Status last verified
Aug 2005
First submitted
22 Aug 2005
Last updated
26 Oct 2005
Results posted
No

Publications

  • VR Edgerton, SL Wolf, DJ Levendowski, RI Jenrich, RR Roy (1997). EMG activity in neck and back muscles during selected static postures in adult males and females. Physiology theory and practice. 13:179-195.

  • VR Edgerton, SL Wolf, DJ Levendowski, RL Roy (1996). Evaluating Patterns of EMG Amplitudes for Trunk and Neck Muscles of Patients and Controls. International Journal of Rehabilitation and Health, 2(1).

  • V.R. Edgerton, S.T. Wolf, D.J. Levendowski, and R.R. Roy (1996). Evaluating Patterns of EMG Amplitudes for Back and Trunk Muscles of Patients and Controls. International Journal of Rehabilitation and Health, 2(1).

  • Edgerton VR, Wolf SL, Levendowski DJ, Roy RR. Theoretical basis for patterning EMG amplitudes to assess muscle dysfunction. Med Sci Sports Exerc. 1996 Jun;28(6):744-51. doi: 10.1097/00005768-199606000-00013.

    PubMed 8784762

Questions about this trial

What is this clinical trial studying?

A study testing Muscle Pattern Recognition (MPR) in people with Neck Pain and Low Back Pain, run by iTech Medical, Inc. at 4 sites in 2 countries.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 10 inclusion and 10 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 26 Oct 2005. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 4 sites in United States, Canada. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Suzan D Olson, PhD, MHS, RN (269.329.3517, solson@midwestcct.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

This study will demonstrate differences in muscle recruitment patterns between individuals who are "normal" (asymptomatic, able-bodied) from those individuals ("not normal") with underlying biomechanical dysfunction of the neck and back. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT00134225, which also lists 4 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Oct 2005.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in